Company Filing History:
Years Active: 1999
Title: Fred Jarl Nyberg: Innovator in Opioid Receptor Research
Introduction
Fred Jarl Nyberg is a notable inventor based in Upsala, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of oligopeptides with affinity to opioid receptors. His work has implications for pain management and addiction treatment.
Latest Patents
Fred Jarl Nyberg holds a patent for "Oligopeptides with affinity to opioid receptors." This innovation represents a step forward in understanding how certain peptides can interact with opioid receptors, potentially leading to new therapeutic options.
Career Highlights
Nyberg is associated with Pharmacia & Upjohn Aktiebolag, a company known for its research and development in pharmaceuticals. His role there has allowed him to focus on groundbreaking research that addresses critical health issues.
Collaborations
Throughout his career, Nyberg has collaborated with talented individuals such as Karin Ingeborg Fholenhag and Linda Fryklund. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Fred Jarl Nyberg's contributions to the field of opioid receptor research highlight his role as an important inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical science.